320 related articles for article (PubMed ID: 30058711)
1. Natural products - alpha-lipoic acid and acetyl-L-carnitine - in the treatment of chemotherapy-induced peripheral neuropathy.
Dinicola S; Fuso A; Cucina A; Santiago-Reyes M; Verna R; Unfer V; Monastra G; Bizzarri M
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4739-4754. PubMed ID: 30058711
[TBL] [Abstract][Full Text] [Related]
2. Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic review.
Schloss JM; Colosimo M; Airey C; Masci PP; Linnane AW; Vitetta L
Clin Nutr; 2013 Dec; 32(6):888-93. PubMed ID: 23647723
[TBL] [Abstract][Full Text] [Related]
3. Acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy: a short review.
De Grandis D
CNS Drugs; 2007; 21 Suppl 1():39-43; discussion 45-6. PubMed ID: 17696592
[TBL] [Abstract][Full Text] [Related]
4. Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review.
Brami C; Bao T; Deng G
Crit Rev Oncol Hematol; 2016 Feb; 98():325-34. PubMed ID: 26652982
[TBL] [Abstract][Full Text] [Related]
5. The role of diet and non-pharmacologic supplements in the treatment of chronic neuropathic pain: A systematic review.
Frediani JK; Lal AA; Kim E; Leslie SL; Boorman DW; Singh V
Pain Pract; 2024 Jan; 24(1):186-210. PubMed ID: 37654090
[TBL] [Abstract][Full Text] [Related]
6. Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera
Desideri I; Francolini G; Becherini C; Terziani F; Delli Paoli C; Olmetto E; Loi M; Perna M; Meattini I; Scotti V; Greto D; Bonomo P; Sulprizio S; Livi L
Med Oncol; 2017 Mar; 34(3):46. PubMed ID: 28205185
[TBL] [Abstract][Full Text] [Related]
7. A Narrative Review of Complementary Nutritional Supplements for Chemotherapy-induced Peripheral Neuropathy.
Liu YW; Liu CT; Su YL; Tsai MY
Altern Ther Health Med; 2020 Jul; 26(4):43-49. PubMed ID: 31634876
[TBL] [Abstract][Full Text] [Related]
8. Herbal medicines and chemotherapy induced peripheral neuropathy (CIPN): A critical literature review.
Schloss J; Colosimo M; Vitetta L
Crit Rev Food Sci Nutr; 2017 Apr; 57(6):1107-1118. PubMed ID: 25849070
[TBL] [Abstract][Full Text] [Related]
9. Modulation by Ozone Therapy of Oxidative Stress in Chemotherapy-Induced Peripheral Neuropathy: The Background for a Randomized Clinical Trial.
Clavo B; Martínez-Sánchez G; Rodríguez-Esparragón F; Rodríguez-Abreu D; Galván S; Aguiar-Bujanda D; Díaz-Garrido JA; Cañas S; Torres-Mata LB; Fabelo H; Téllez T; Santana-Rodríguez N; Fernández-Pérez L; Marrero-Callico G
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802143
[TBL] [Abstract][Full Text] [Related]
10. Ganglioside-monosialic acid (GM1) for prevention of chemotherapy-induced peripheral neuropathy: a meta-analysis with trial sequential analysis.
Wu S; Bai X; Guo C; Huang Z; Ouyang H; Huang J; Zeng W
BMC Cancer; 2021 Nov; 21(1):1173. PubMed ID: 34727879
[TBL] [Abstract][Full Text] [Related]
11. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.
Kleckner IR; Kamen C; Gewandter JS; Mohile NA; Heckler CE; Culakova E; Fung C; Janelsins MC; Asare M; Lin PJ; Reddy PS; Giguere J; Berenberg J; Kesler SR; Mustian KM
Support Care Cancer; 2018 Apr; 26(4):1019-1028. PubMed ID: 29243164
[TBL] [Abstract][Full Text] [Related]
12. Medicinal plants and their isolated phytochemicals for the management of chemotherapy-induced neuropathy: therapeutic targets and clinical perspective.
Oveissi V; Ram M; Bahramsoltani R; Ebrahimi F; Rahimi R; Naseri R; Belwal T; Devkota HP; Abbasabadi Z; Farzaei MH
Daru; 2019 Jun; 27(1):389-406. PubMed ID: 30852764
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.
Wolf S; Barton D; Kottschade L; Grothey A; Loprinzi C
Eur J Cancer; 2008 Jul; 44(11):1507-15. PubMed ID: 18571399
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives.
Ewertz M; Qvortrup C; Eckhoff L
Acta Oncol; 2015 May; 54(5):587-91. PubMed ID: 25751757
[TBL] [Abstract][Full Text] [Related]
15. Goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.
Kuriyama A; Endo K
Support Care Cancer; 2018 Apr; 26(4):1051-1059. PubMed ID: 29280005
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy-Induced Peripheral Neuropathy: Causative Agents, Preventative Strategies, and Treatment Approaches.
Kachrani R; Santana A; Rogala B; Pawasauskas J
J Pain Palliat Care Pharmacother; 2020 Sep; 34(3):141-152. PubMed ID: 32118502
[TBL] [Abstract][Full Text] [Related]
17. Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review.
Chu SH; Lee YJ; Lee ES; Geng Y; Wang XS; Cleeland CS
Support Care Cancer; 2015 Feb; 23(2):513-24. PubMed ID: 25256375
[TBL] [Abstract][Full Text] [Related]
18. Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives.
Poupon L; Kerckhove N; Vein J; Lamoine S; Authier N; Busserolles J; Balayssac D
Expert Opin Drug Saf; 2015 Aug; 14(8):1269-82. PubMed ID: 26058312
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial dysfunction in the pathogenesis of chemotherapy-induced peripheral neuropathy.
Trecarichi A; Flatters SJL
Int Rev Neurobiol; 2019; 145():83-126. PubMed ID: 31208528
[TBL] [Abstract][Full Text] [Related]
20. Statistical identification of predictors for peripheral neuropathy associated with administration of bortezomib, taxanes, oxaliplatin or vincristine using ordered logistic regression analysis.
Kanbayashi Y; Hosokawa T; Okamoto K; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Taniwaki M
Anticancer Drugs; 2010 Oct; 21(9):877-81. PubMed ID: 20679888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]